GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » Sloan Ratio %

Clarivate (Clarivate) Sloan Ratio % : -11.16% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Clarivate Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Clarivate's Sloan Ratio for the quarter that ended in Dec. 2023 was -11.16%.

As of Dec. 2023, Clarivate has a Sloan Ratio of -11.16%, indicating there is a warning stage of accrual build up.


Clarivate Sloan Ratio % Historical Data

The historical data trend for Clarivate's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarivate Sloan Ratio % Chart

Clarivate Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial -6.21 16.06 17.09 -32.46 -11.16

Clarivate Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.46 -33.68 -36.19 -3.67 -11.16

Competitive Comparison of Clarivate's Sloan Ratio %

For the Information Technology Services subindustry, Clarivate's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clarivate's Sloan Ratio % Distribution in the Software Industry

For the Software industry and Technology sector, Clarivate's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Clarivate's Sloan Ratio % falls into.



Clarivate Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Clarivate's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-911.2-744.2
--237.4)/12706.8
=-11.16%

Clarivate's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-911.2-744.2
--237.4)/12706.8
=-11.16%

Clarivate's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 43.5 (Mar. 2023 ) + -123.1 (Jun. 2023 ) + 12.3 (Sep. 2023 ) + -843.9 (Dec. 2023 ) = $-911 Mil.
Clarivate's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 227.5 (Mar. 2023 ) + 162.4 (Jun. 2023 ) + 163.4 (Sep. 2023 ) + 190.9 (Dec. 2023 ) = $744 Mil.
Clarivate's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -60.4 (Mar. 2023 ) + -47.1 (Jun. 2023 ) + -62.9 (Sep. 2023 ) + -67 (Dec. 2023 ) = $-237 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clarivate  (NYSE:CLVT) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Clarivate has a Sloan Ratio of -11.16%, indicating there is a warning stage of accrual build up.


Clarivate Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Clarivate's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clarivate (Clarivate) Business Description

Traded in Other Exchanges
Address
70 St. Mary Axe, London, GBR, EC3A 8BE
Clarivate PLC is an information, analytics, and workflow solutions company. It operates in three segments: Academia and Government; Life Sciences and Healthcare and Intellectual Property. The company generates maximum revenue from the Academia and Government segment. The A&G segment consists of Academia and Government product group, which drives research excellence across institutions, empower researchers to tackle today's global challenges and help academic institutions and libraries improve operational efficiency and effectiveness. Geographically, it derives a majority of its revenue from the Americas.
Executives
Melanie Margolin officer: Chief Legal Officer 1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905
Saurabh Saha director C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT
Henry Levy officer: President, LS&H 70 ST. MARY AXE, LONDON X0 EC3 8BA
Bar Veinstein officer: President, A&G 70 ST. MARY AXE, LONDON X0 EC3 8BA
James Gordon Samson officer: President, IP Group FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ
Andrew Miles Snyder director 111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019
Wendell E. Pritchett director TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Jonathan Gear director, officer: Chief Executive Officer-Elect C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Michael M Easton officer: Senior VP, Finance/CAO 4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Stefano Maestri officer: Chief Technology Officer 70 ST MARY AXE, LONDON X0 EC3 8BA
Jonathan Mark Collins officer: Executive Vice President/CFO 50196 VENICE COURT, NORTHVILLE MI 48168
Mukhtar Ahmed officer: President, Science Group FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Michael J Angelakis director 40 MORRIS AVENUE, BRYN MAWR PA 19010
Heather Matzke-hamlin officer: Acting Chief Acctg Officer 4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Steen Lomholt-thomsen officer: Chief Revenue Officer FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE1 8EZ